Subacute cutaneous lupus erythematosus as a rare complication of disease-modifying therapy administration in multiple sclerosis: case report.

Author: FengJinzhou, QinXinyue, XuKe, YangShilin, YuGang, ZhangMengjie, ZhengPeng

Paper Details 
Original Abstract of the Article :
Teriflunomide, the active metabolite of leflunomide, is a disease-modifying therapy drug used for the treatment of multiple sclerosis (MS), yet the complications associated with this drug remain not fully understood. Here we present the rare case of a 28-year-old female MS patient who developed suba...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131458/

データ提供:米国国立医学図書館(NLM)

Subacute Cutaneous Lupus Erythematosus: A Rare Desert Storm

Multiple sclerosis (MS) is like a desert storm, relentlessly attacking the central nervous system. This research presents a rare case of a patient with MS who developed subacute cutaneous lupus erythematosus (SCLE) after receiving treatment with teriflunomide, a disease-modifying therapy. It's like discovering a hidden oasis in the desert, revealing a potential side effect of a widely used medication.

Uncovering the Unexpected: A Cautionary Tale

The case report, like a flickering lantern in the desert, illuminates a previously unknown side effect of teriflunomide. It's like a desert mirage, revealing a hidden danger. The researchers highlight the potential for SCLE to develop as a complication of teriflunomide treatment, particularly in women with a preexisting autoimmune diathesis.

Navigating the Risks: A Call for Vigilance

This case report serves as a reminder of the importance of careful monitoring and vigilant observation in medical practice. It's like a compass guiding us through the complexities of medical treatment, ensuring the safety and well-being of patients. Further research is needed to fully understand the relationship between teriflunomide and SCLE, but this case report highlights the potential for this serious complication.

Dr. Camel's Conclusion

This research is like a desert journey, reminding us of the unpredictable nature of medical outcomes. It highlights the importance of vigilant monitoring and careful consideration of potential side effects, ensuring the safety and well-being of patients.

Date :
  1. Date Completed 2023-04-28
  2. Date Revised 2023-04-29
Further Info :

Pubmed ID

37101279

DOI: Digital Object Identifier

PMC10131458

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.